ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2025
Labeling Corynebacterium pseudotuberculosis using superfolder green fluorescent protein to evaluate its infection in macrophages.
Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Superfolder Green Fluorescent Protein (sfGFP): A Versatile Tool for Biotechnology Research.Applied biochemistry and biotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
To develop a visual detection method for Corynebacterium pseudotuberculosis (CP), a Gram-positive and facultative intracellular bacterium that causes chronic suppurative diseases in humans and animals, we constructed a superfolder green fluorescent protein (sfGFP) expression plasmid, pXMJ19-sfGFP, which constitutively expresses sfGFP in CP. The effects of pXMJ19-sfGFP on the biological characteristics of CP were evaluated, and no significant effects on the morphology, growth, or pathogenicity of CP were noticed following sfGFP expression. The stability of pXMJ19-sfGFP was determined through sequential propagation and infection tests in macrophages and mice. pXMJ19-sfGFP was stable within CP in the presence of chloramphenicol; however, certain degree of plasmid loss was noticed without antibiotic selection pressure. The rates of loss of pXMJ19-sfGFP in CP recovered from the macrophages infected with sfGFP-labeled strains of different pathogenicity were similar, indicating the feasibility of sfGFP-labeled CP monitoring during infection of macrophages by bacteria. The rate of macrophage infection with sfGFP-labeled CP with or without phospholipase D (pld) mutation was evaluated using flow cytometry, and the results showed that the rate of macrophage infection by CP was significantly higher than that by mutant CP. Therefore, sfGFP expression in CP is a valuable tool for visual analysis of macrophage infection by CP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.